Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06212921
Other study ID # BIPAMI study
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2024
Est. completion date September 2025

Study information

Verified date January 2024
Source University of Tartu
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 250
Est. completion date September 2025
Est. primary completion date September 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years or older - Initial decision in favour of further diagnostics of mesenteric ischaemia Exclusion Criteria: - Age <18 years - Consent declined by patient or next of kin (delayed consent) - Chronic mesenteric ischaemia without an acute event - Immediate decision for withdrawal of further diagnostics and active treatment - Referral from another hospital with already established diagnosis of AMI - AMI diagnosed at surgery without previously having been considered

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Sequential blood samples
Sequential blood samples for diagnostic tests is the only intervention in thei study

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Tartu

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of correctly predicted cases of acute mesenteric ischaemia Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers 10 months
See also
  Status Clinical Trial Phase
Recruiting NCT05194527 - The Detrimental Course of Acute Intestinal Ischemia
Not yet recruiting NCT06387147 - ORal Antibiotics In Acute Mesenteric Ischemia Phase 3
Completed NCT04867499 - Epidemiology of Acute Mesenteric Ischemia
Recruiting NCT03518099 - Searching Biomarkers of Acute Intestinal Ischemic Injuries N/A
Not yet recruiting NCT06428240 - Acute Mesenteric Ischemia, Reality in Catalonia
Active, not recruiting NCT06365827 - Perioperatively Assessed Biomarker I-FABP Level for Prediction of Acute Mesenteric Ischemia and Its Correlation With Acute Kidney Injury, Followed by Extracorporeal Circulation (aMIKI)
Recruiting NCT06445660 - The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia
Completed NCT05218863 - Incidence, Diagnosis, Management and Outcome of Acute Mesenteric Ischemia
Completed NCT05706012 - Antithrombotic Management of Acute Mesenteric Ischaemia
Not yet recruiting NCT06310395 - Analysis of the Acute Mesenteric Ischemia in a Single Institution Over 10 Years
Completed NCT05665946 - Acute Intestinal Necrosis- the Preoperative Diagnostic Approach
Recruiting NCT01788904 - Plasma i-FABP as Predictor for Irreversible Bowel Ischemia N/A
Recruiting NCT02772913 - Mesenteric Ischemia in the Emergency Department: a Retrospective Multicenter Study N/A